アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

nexgen pharma, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - codeine phosphate 54.3 mg - codeine phosphate and chlorpheniramine maleate is indicated for the relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older. important limitations of use not indicated for pediatric patients under 18 years of age [see use in special population (8.4)] patients with known hypersensitivity to codeine, chlorpheniramine or any of the inactive ingredients of codeine phosphate and chlorpheniramine maleate. persons known to be hypersensitive to certain other opioids may exhibit cross-sensitivity to codeine. teratogenic effects pregnancy category c there are no adequate and well-controlled studies of codeine phosphate and chlorpheniramine maleate in pregnant women. reproductive toxicity studies have not been conducted with codeine phosphate and chlorpheniramine maleate; however, studies are available with individual active ingredients or related active ingredients. because animal reproduction studies are not always predictive of human response, co

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

physicians total care, inc. - codeine sulfate (unii: 11qv9bs0cb) (codeine - unii:q830pw7520) - codeine sulfate 60 mg - codeine sulfate is an opioid analgesic indicated for the relief of mild to moderately severe pain where the use of an opioid analgesic is appropriate. codeine sulfate is contraindicated in patients with known hypersensitivity to codeine or any components of the product. persons known to be hypersensitive to certain other opioids may exhibit cross-sensitivity to codeine. codeine sulfate is contraindicated in patients with respiratory depression in the absence of resuscitative equipment. codeine sulfate is contraindicated in patients with acute or severe bronchial asthma or hypercarbia. codeine sulfate is contraindicated in any patient who has or is suspected of having paralytic ileus. enter section text here codeine sulfate is an opioid agonist and is a schedule ii controlled substance. codeine sulfate can be abused and is subject to criminal diversion.  drug addiction is characterized by compulsive use, use for non-medical purposes, and continued use despite harm or risk of harm. drug addiction is

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - codeine phosphate - oral tablet - 60mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - codeine phosphate - oral tablet - 60mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - paracetamol; caffeine - effervescent tablet - 500mg ; 65mg

イスラエル - 英語 - Ministry of Health

taro pharmaceutical industries ltd - caffeine; codeine phosphate; paracetamol - caplets - paracetamol 500 mg; caffeine 30 mg; codeine phosphate 10 mg - paracetamol - paracetamol - for the relief of pain and coughs and for the reduction of fever accompanied by pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet - excipient ingredients: povidone; stearic acid; magnesium stearate; pregelatinised maize starch - short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet - excipient ingredients: magnesium stearate; stearic acid; povidone; pregelatinised maize starch - short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet - excipient ingredients: pregelatinised maize starch; magnesium stearate; stearic acid; povidone - short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 15 mg - tablet, uncoated - excipient ingredients: stearic acid; sodium lauryl sulfate; maize starch; colloidal anhydrous silica; pregelatinised maize starch; purified talc; hyprolose; magnesium stearate; povidone - for the temporary relief of acute moderate pain